BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2900001)

  • 1. Vasopressin modulates the activity of nicotinic cholinergic mechanisms during memory retrieval in mice.
    Faiman CP; de Erausquin GA; Baratti CM
    Behav Neural Biol; 1988 Jul; 50(1):112-9. PubMed ID: 2900001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mecamylamine prevents the enhancement of retention induced by lysine vasopressin in mice.
    Faiman CP; De Erausquin GA; Baratti CM
    Behav Neural Biol; 1987 Nov; 48(3):434-9. PubMed ID: 3689289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enhancement of retention induced by vasopressin in mice may be mediated by an activation of central nicotinic cholinergic mechanisms.
    Faiman CP; de Erausquin GA; Baratti CM
    Behav Neural Biol; 1991 Sep; 56(2):183-99. PubMed ID: 1759940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of memory retrieval by pre-testing vasopressin: involvement of a central cholinergic nicotinic mechanism.
    Faiman CP; de Erausquin GA; Baratti CM
    Methods Find Exp Clin Pharmacol; 1992 Oct; 14(8):607-13. PubMed ID: 1494301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitation of inhibitory avoidance by hypertonic saline is reversed by a vasopressin and a nicotinic antagonist.
    Baratti CM; Faiman CP; de Erausquin GA
    Behav Neural Biol; 1989 May; 51(3):424-35. PubMed ID: 2525022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of central cholinergic mechanisms in the effects of oxytocin and an oxytocin receptor antagonist on retention performance in mice.
    Boccia MM; Baratti CM
    Neurobiol Learn Mem; 2000 Nov; 74(3):217-28. PubMed ID: 11031128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central cholinergic control of vasopressin release in conscious rats.
    Iitake K; Share L; Ouchi Y; Crofton JT; Brooks DP
    Am J Physiol; 1986 Aug; 251(2 Pt 1):E146-50. PubMed ID: 2874742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impairment of retention induced by beta-endorphin in mice may be mediated by a reduction of central cholinergic activity.
    Introini IB; Baratti CM
    Behav Neural Biol; 1984 Jul; 41(2):152-63. PubMed ID: 6148931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose effects on mecamylamine-induced memory deficits and decreases in locomotor activity in mice.
    Ragozzino ME; Gold PE
    Behav Neural Biol; 1991 Nov; 56(3):271-82. PubMed ID: 1759947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation of memory storage by the acetylcholine M2 muscarinic receptor antagonist AF-DX 116.
    Baratti CM; Opezzo JW; Kopf SR
    Behav Neural Biol; 1993 Jul; 60(1):69-74. PubMed ID: 8216161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol state-dependent memory: involvement of dorsal hippocampal muscarinic and nicotinic receptors.
    Rezayof A; Alijanpour S; Zarrindast MR; Rassouli Y
    Neurobiol Learn Mem; 2008 May; 89(4):441-7. PubMed ID: 18065245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning.
    Riekkinen P; Sirviö J; Aaltonen M; Riekkinen P
    Pharmacol Biochem Behav; 1990 Nov; 37(3):405-10. PubMed ID: 2087481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible interaction between central cholinergic muscarinic and opioid peptidergic systems during memory consolidation in mice.
    Baratti CM; Introini IB; Huygens P
    Behav Neural Biol; 1984 Mar; 40(2):155-69. PubMed ID: 6732709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of brain acetylcholine in vasopressin release during osmotic stimulation and hemorrhage.
    Iitake K; Share L; Brooks DP; Crofton JT; Ouchi Y
    Exp Brain Res; 1989; 75(1):47-52. PubMed ID: 2565246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory-modulatory effects of centrally acting noradrenergic drugs: possible involvement of brain cholinergic mechanisms.
    Introini-Collison IB; Baratti CM
    Behav Neural Biol; 1992 May; 57(3):248-55. PubMed ID: 1319706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory-improving actions of glucose: involvement of a central cholinergic muscarinic mechanism.
    Kopf SR; Baratti CM
    Behav Neural Biol; 1994 Nov; 62(3):237-43. PubMed ID: 7857246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice.
    Boccia MM; Kopf SR; Baratti CM
    Neurobiol Learn Mem; 1998 Mar; 69(2):136-46. PubMed ID: 9619993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory improving actions of gabapentin in mice: possible involvement of central muscarinic cholinergic mechanism.
    Boccia MM; Acosta GB; Baratti CM
    Neurosci Lett; 2001 Oct; 311(3):153-6. PubMed ID: 11578817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A central link between angiotensinergic and cholinergic systems; role of vasopressin.
    Buyukcoskun NI; Gulec G; Ozluk K
    Peptides; 2001 Sep; 22(9):1415-20. PubMed ID: 11514022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by arecoline and differential effects of muscarinic and nicotinic antagonists.
    McGurk SR; Levin ED; Butcher LL
    Neuroscience; 1991; 44(1):137-47. PubMed ID: 1770993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.